help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 6, No. 12 2257-2265
doi:10.1210/me.6.12.2257
Copyright © 1992 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baertschi, A. J.
Right arrow Articles by Vincent, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baertschi, A. J.
Right arrow Articles by Vincent, J. D.

Molecular Endocrinology, Vol 6, 2257-2265, Copyright © 1992 by Endocrine Society


ARTICLES

Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors

AJ Baertschi, Y Audigier, PM Lledo, JM Israel, J Bockaert and JD Vincent
Department of Physiology, University of Virginia, Charlottesville 22908.

This article describes a new approach for determining the role of endogenous guanine nucleotide binding (G) protein subunits in signal transduction. Sequential patch-clamping was applied to BSA gradient- enriched cultured lactotropes from lactating rats, first to dialyze antisense oligodeoxyribonucleotides (AS) directed against G alpha protein mRNAs and 48 h later to record ion-current responses to the PRL release inhibitor, dopamine. The effectiveness and specificity of action of six types of AS were determined by their effects on the in vitro translation of alpha o, alpha i1, alpha i2, alpha i3, and alpha s. The specificity of AS could be enhanced by replacing guanine by cytosine bases within the center core of AS and by maximizing the number of mismatches against nontargeted mRNAs within the extremities of AS. A total of 59 out of 240 cells could be investigated using the sequential patch clamp procedure in the absence of antibiotics. The typical decrease of the voltage-activated calcium current in response to 10 nM dopamine was diminished or abolished by AS, in correlation with the inhibition of in vitro translation of the alpha o subunit. The typical increase of the voltage-activated potassium current in response to dopamine was abolished by AS directed against alpha i3 but not alpha o mRNA. Control experiments showed that culture conditions or loss of receptor affinity for dopamine were not responsible for the loss of response. The results suggest that dopamine D2 receptors are linked via alpha o to calcium channels and via alpha i3 to potassium channels.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
A. C. Dolphin
G Protein Modulation of Voltage-Gated Calcium Channels
Pharmacol. Rev., December 1, 2003; 55(4): 607 - 627.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. R. Albert
G Protein Preferences for Dopamine D2 Inhibition of Prolactin Secretion and DNA Synthesis in GH4 Pituitary Cells
Mol. Endocrinol., August 1, 2002; 16(8): 1903 - 1911.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Kilts, H. S. Connery, E. G. Arrington, M. M. Lewis, C. P. Lawler, G. S. Oxford, K. L. O'Malley, R. D. Todd, B. L. Blake, D. E. Nichols, et al.
Functional Selectivity of Dopamine Receptor Agonists. II. Actions of Dihydrexidine in D2L Receptor-Transfected MN9D Cells and Pituitary Lactotrophs
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1179 - 1189.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. R. Albert
Editorial: Dopamine-D2-Mediated Inhibition of TRH-Induced PLC Activation in Pituitary Cells--Direct or Indirect?
Endocrinology, March 1, 2002; 143(3): 744 - 746.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy
Prolactin: Structure, Function, and Regulation of Secretion
Physiol Rev, October 1, 2000; 80(4): 1523 - 1631.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. C Dolphin
Mechanisms of modulation of voltage-dependent calcium channels by G proteins
J. Physiol., January 1, 1998; 506(1): 3 - 11.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON
Dopamine Receptors: From Structure to Function
Physiol Rev, January 1, 1998; 78(1): 189 - 225.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Takano, J. Yasufuku-Takano, A. Teramoto, and T. Fujita
Gi3 Mediates Somatostatin-Induced Activation of an Inwardly Rectifying K+ Current in Human Growth Hormone-Secreting Adenoma Cells
Endocrinology, June 1, 1997; 138(6): 2405 - 2409.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Z. Yan, W.-J. Song, and D. J. Surmeier
D2 Dopamine Receptors Reduce N-Type Ca2+ Currents in Rat Neostriatal Cholinergic Interneurons Through a Membrane-Delimited, Protein-Kinase-C-Insensitive Pathway
J Neurophysiol, February 1, 1997; 77(2): 1003 - 1015.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Lew and H. P. Elsholtz
A Dopamine-responsive Domain in the N-terminal Sequence of Pit-1
J. Biol. Chem., March 31, 1995; 270(13): 7156 - 7160.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society